fashion -WSS

fashion

author：leisure time 2025-08-26 23:48:30 - browse：63

Illumina, the largest maker of DNA-sequencing technology and a storied name in the biotechnology industry, named Jacob Thaysen, a 10-year-veteran at life sciences-tools firm Agilent, as its new CEO.

The appointment follows a bitter board fight that ended with the departure of Francis deSouza, who had been Illumina’s CEO since 2016. The battle, tipped off by Illumina’s troubled acquisition of cancer diagnostics firm Grail, had involved a proxy fight staged by activist investor Carl Icahn.

During the battle, there had been speculation that Jay Flatley, deSouza’s predecessor, could return. Under Flatley, Illumina had grown from an upstart to the dominant player in a field that has proved pivotal for medical research and delivered sizable returns to investors.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： FDA warns medical device makers about rise in fabricated data

WSS

Medicare Advantage enrollment hits roughly 33.4 million

As Maui death toll rises, number of missing remains unclear

Measles policy set amid Florida outbreak alarms vaccine proponents

ActiGraph execs on goal of drug approvals with digital endpoints

Congress must give Medicare recipients genetic counseling access

Obamacare plans could cover weight loss drugs

explore

fashion

entertainment

In age of alternative facts, a scholarly course on calling out crap

Readout Newsletter: Sarepta, Alnylam, and Royalty Pharma

DIEP, the 'gold standard' of breast reconstruction, is under threat

Majority of Americans think Trump's Ga. election interference case is serious: POLL

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Congress must give Medicare recipients genetic counseling access

How one medical school became remarkably diverse

Living with Hashimoto's and celiac disease, and med school, too

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Obamacare plans could cover weight loss drugs

entertainment

Evacuations in place as 3 wildfires burn in eastern Washington state

Readout Newsletter: Sarepta, Alnylam, and Royalty Pharma

Hilary may become 1st tropical storm to make landfall in California in 84 years

WATCH: Why do our ears pop?

Congress must give Medicare recipients genetic counseling access

Readout Newsletter: Bayer, Rapt Therapeutics, Sanofi shortage

focus

Wikipedia

focus

entertainment